Published mark

CHAMPIONS ONCOLOGY, INC.

NASDAQ: CSBR. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:10800b23-8d27-4d12-9981-ec416136766c
SEC CIK
0000771856
Record version
vpublic-1, published Oct 6, 2026
Newest evidence
Aug 22, 2025
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Ronnie MorrisSince Aug 22, 2025
Chair
Not published
Independent
5 / 77 directors published
Published claims
242 distinct sources
Evidence records
60 pinned
Source conflicts
0None open

Built from 2 distinct sources and 6 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Brady Davis executive of CHAMPIONS ONCOLOGY, INC., effective 2025-08-22.

EffectiveEffective Aug 22, 2025E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
PresidentBrady DavisAug 2025currentSource reportedE3
Chief Financial OfficerDavid MillerAug 2025currentSource reportedE4
Chief Executive OfficerRonnie MorrisAug 2025currentSource reportedE5

Board of directors

Evidence

7 directors published. 5 of 7 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Daniel MendelsonIndependent2013AuditAudit; Compensation; Nominating and GovernanceCompensationNominating and GovernanceSource reportedE2
David Sidransky, M.D.Independent2007None publishedSource reportedE2
Joel AckermanIndependent2010AuditSource reportedE2
Philip Breitfeld, M.D.Independent2016None publishedSource reportedE2
Robert BraininNot independent2021Nominating and GovernanceSource reportedE2
Ronnie Morris, M.D.Not independent2010None publishedSource reportedE2
Scott R. TobinIndependent2011Audit, chairAudit · Chair; CompensationCompensationSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditScott R. TobinScott R. Tobin, Daniel Mendelson, Joel Ackerman, Scott R. Tobin, Daniel Mendelson, Joel Ackerman, Joel AckermanNot described in the published record
Audit · Chair; CompensationNot publishedScott R. TobinNot described in the published record
Audit; Compensation; Nominating and GovernanceNot publishedDaniel MendelsonNot described in the published record
CompensationNot publishedDaniel Mendelson, Scott R. Tobin, Daniel Mendelson, Scott R. TobinNot described in the published record
Nominating and GovernanceNot publishedDaniel Mendelson, Robert Brainin, Daniel Mendelson, Robert Brainin, Robert BraininNot described in the published record
Committee RecordAudit: Chair Scott R. Tobin; Members Scott R. Tobin (Chair); Daniel Mendelson; Joel Ackerman
Source reportedE6
company:10800b23-8d27-4d12-9981-ec416136766c:committee_record:15
Committee AppointmentScott R. Tobin: chair, Audit
Source reportedE6
company:10800b23-8d27-4d12-9981-ec416136766c:committee_appointment:16
Committee AppointmentDaniel Mendelson: member, Audit
Source reportedE6
company:10800b23-8d27-4d12-9981-ec416136766c:committee_appointment:17
Committee AppointmentJoel Ackerman: member, Audit
Source reportedE6
company:10800b23-8d27-4d12-9981-ec416136766c:committee_appointment:18
Committee RecordCompensation: Chair not stated; Members Daniel Mendelson; Scott R. Tobin
Source reportedE6
company:10800b23-8d27-4d12-9981-ec416136766c:committee_record:19
Committee AppointmentDaniel Mendelson: member, Compensation
Source reportedE6
company:10800b23-8d27-4d12-9981-ec416136766c:committee_appointment:20
Committee AppointmentScott R. Tobin: member, Compensation
Source reportedE6
company:10800b23-8d27-4d12-9981-ec416136766c:committee_appointment:21
Committee RecordNominating and Governance: Chair not stated; Members Daniel Mendelson; Robert Brainin
Source reportedE6
company:10800b23-8d27-4d12-9981-ec416136766c:committee_record:22
Committee AppointmentDaniel Mendelson: member, Nominating and Governance
Source reportedE6
company:10800b23-8d27-4d12-9981-ec416136766c:committee_appointment:23
Committee AppointmentRobert Brainin: member, Nominating and Governance
Source reportedE6
company:10800b23-8d27-4d12-9981-ec416136766c:committee_appointment:24

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerRonnie Morris, Chief Executive Officer, from Aug 22, 2025
Source reportedE5
company:10800b23-8d27-4d12-9981-ec416136766c:leadership_role:14
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingCSBR (NASDAQ)
Source reportedE1
company:10800b23-8d27-4d12-9981-ec416136766c:security_listing:25
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 6, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameCHAMPIONS ONCOLOGY, INC.
Source reportedE1
company:10800b23-8d27-4d12-9981-ec416136766c:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:10800b23-8d27-4d12-9981-ec416136766c:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
6 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 6, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    CHAMPIONS ONCOLOGY, INC. DEF 14A 2025-08-22
    sec proxy. Published Aug 22, 2025. Retrieved Apr 28, 2026. Cited by 7 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    CSBR DEF 14A executive officers
    sec filing. Published Aug 22, 2025. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    CSBR DEF 14A executive officers
    sec filing. Published Aug 22, 2025. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    CSBR DEF 14A executive officers
    sec filing. Published Aug 22, 2025. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    Audit
    board_seats. board seats. Cited by 10 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1

vpublic-1 published Oct 6, 2026
  • Brady Davis executive of CHAMPIONS ONCOLOGY, INC., effective 2025-08-22.
  • David Miller executive of CHAMPIONS ONCOLOGY, INC., effective 2025-08-22.
  • Ronnie Morris executive of CHAMPIONS ONCOLOGY, INC., effective 2025-08-22.
  • Robert Brainin seat on CHAMPIONS ONCOLOGY, INC., effective 2021-01-01.
  • Robert Brainin member of Nominating and Governance, effective 2021-01-01.
  • Philip Breitfeld, M.D. seat on CHAMPIONS ONCOLOGY, INC., effective 2016-01-01.
  • Daniel Mendelson seat on CHAMPIONS ONCOLOGY, INC., effective 2013-01-01.
  • Audit; Compensation; Nominating and Governance committee of CHAMPIONS ONCOLOGY, INC., effective 2013-01-01.
  • Daniel Mendelson member of Audit; Compensation; Nominating and Governance, effective 2013-01-01.
  • Scott R. Tobin seat on CHAMPIONS ONCOLOGY, INC., effective 2011-01-01.
  • Audit · Chair; Compensation committee of CHAMPIONS ONCOLOGY, INC., effective 2011-01-01.
  • Scott R. Tobin member of Audit · Chair; Compensation, effective 2011-01-01.
  • Joel Ackerman seat on CHAMPIONS ONCOLOGY, INC., effective 2010-01-01.
  • Ronnie Morris, M.D. seat on CHAMPIONS ONCOLOGY, INC., effective 2010-01-01.
  • Joel Ackerman member of Audit, effective 2010-01-01.
  • David Sidransky, M.D. seat on CHAMPIONS ONCOLOGY, INC., effective 2007-01-01.

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership3
  4. Board7
  5. Committees5
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people10
  17. Subject and corrections6
  18. Evidence6
  19. Version historyvpublic-1

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:10800b23-8d27-4d12-9981-ec416136766c
  • Cite this recordCHAMPIONS ONCOLOGY, INC.
  • Copy canonical URLregistry.alpha.ac/companies/champions-oncology-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    CHAMPIONS ONCOLOGY, INC.Company
  • Brady DavisPerson
  • David MillerPerson
  • Ronnie MorrisPerson
  • Daniel MendelsonPerson
  • David Sidransky, M.D.Person
  • Joel AckermanPerson
  • Philip Breitfeld, M.D.Person
  • Robert BraininPerson
  • Ronnie Morris, M.D.Person
  • Scott R. TobinPerson
  • Sections
    OverviewCHAMPIONS ONCOLOGY, INC.
  • MonitoringCHAMPIONS ONCOLOGY, INC.
  • LeadershipCHAMPIONS ONCOLOGY, INC.
  • BoardCHAMPIONS ONCOLOGY, INC.
  • CommitteesCHAMPIONS ONCOLOGY, INC.
  • Control and votingCHAMPIONS ONCOLOGY, INC.
  • Authority to actCHAMPIONS ONCOLOGY, INC.
  • FinancialsCHAMPIONS ONCOLOGY, INC.
  • GovernanceCHAMPIONS ONCOLOGY, INC.
  • RiskCHAMPIONS ONCOLOGY, INC.
  • AI oversightCHAMPIONS ONCOLOGY, INC.
  • LegalCHAMPIONS ONCOLOGY, INC.
  • CompensationCHAMPIONS ONCOLOGY, INC.
  • Other published claimsCHAMPIONS ONCOLOGY, INC.
  • Coverage gapsCHAMPIONS ONCOLOGY, INC.
  • Linked peopleCHAMPIONS ONCOLOGY, INC.
  • Subject and correctionsCHAMPIONS ONCOLOGY, INC.
  • EvidenceCHAMPIONS ONCOLOGY, INC.
  • Version historyCHAMPIONS ONCOLOGY, INC.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.